Precision Biosciences (DTIL) Property, Plant & Equipment (Net) Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 24.11% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 12.18% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.92% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | -56.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.46% |
| Dec 31, 2025 | -53.87% |
| Sep 30, 2025 | -43.14% |
| Jun 30, 2025 | -44.26% |
| Mar 31, 2025 | -48.60% |
| Dec 31, 2024 | -51.26% |
| Sep 30, 2024 | -59.23% |
| Jun 30, 2024 | -76.84% |
| Mar 31, 2024 | -71.57% |
| Dec 31, 2023 | -46.36% |
| Sep 30, 2023 | -59.90% |
| Jun 30, 2023 | -20.84% |
| Mar 31, 2023 | -22.13% |
| Dec 31, 2022 | -53.03% |
| Sep 30, 2022 | -30.90% |
| Jun 30, 2022 | -29.67% |
| Mar 31, 2022 | -29.55% |
| Dec 31, 2021 | -28.32% |
| Sep 30, 2021 | -13.59% |
| Jun 30, 2021 | -12.68% |
| Mar 31, 2021 | -12.63% |
| Dec 31, 2020 | -11.32% |
| Sep 30, 2020 | -6.33% |
| Jun 30, 2020 | 13.89% |
| Mar 31, 2020 | 38.97% |
| Dec 31, 2019 | 87.12% |